Category: Cancer

Cancer

GeneCentric Data Suggest Fragmentomics Could Expand Liquid Biopsy Beyond Mutation Testing

Presentations at AACR 2026 will showcase fragmentomics-based technology for detecting therapeutic markers and providing prognostic insight.

NeoGenomics to Spotlight AI-Driven Genomic–Clinical Data Integration at AACR 2026
Labcorp and Children’s Hospital of Philadelphia Partner to Expand Pediatric Diagnostic Access
Ataraxis AI Launches Test to Predict Response to Neoadjuvant Therapy in Breast Cancer
Blood-Based Biomarker Identifies Cancer Risk in Lynch Syndrome Patients
FDA Clears At-Home Cervical Cancer Screening Tool
Multi-Cancer Early Detection Test Added to Evexia Diagnostics Platform
New Research on Automated Myeloid Testing and Molecular Residual Disease to be Presented at AACR 2026
DecisionDx-Melanoma Gene Expression Test Improves Risk Prediction Beyond Standard Staging
EpiCapture Urine-Based Prostate Cancer Test Shows High Accuracy in Clinical Study

Cancer

Home HPV Self-Sampling Kits Show Promise for Closing Cervical Screening Gap in Disabled Women

A new survey-based study finds that more than half of physically Disabled women would prefer at-home human papillomavirus testing over traditional clinic-based cervical screening.

Cancer

Nucleosome Levels Found Elevated in Trauma Patients at Risk for Blood Clots, Mayo Clinic Study Shows

A Mayo Clinic study of 674 trauma patients found elevated circulating nucleosome levels in those who developed venous thromboembolism, suggesting a potential new biomarker for early VTE risk identification.

Ultrasensitive ctDNA Test Outperforms Standard Metrics in Predicting Breast Cancer Outcomes After Neoadjuvant Therapy

Mar 25, 2026 | Breast

A study found that circulating tumor DNA testing detected residual disease signals missed by conventional prognostic measures in patients with breast cancer.

Primerdesign and Origin Sciences Partner to Optimize DNA Extraction from Rectal Mucus for Colorectal Cancer Detection

Mar 24, 2026 | Colorectal

The collaboration has produced a custom nucleic acid extraction workflow designed to unlock molecular insights from a novel biospecimen and improve diagnostic utility in gut health conditions.

Ibex Medical Analytics Launches Next-Generation AI Pathology Platform

Mar 19, 2026 | Breast, Digital Pathology

Ibex Medical Analytics has launched Ibex 4, an AI-powered pathology platform with expanded end-to-end breast cancer diagnostic workflows, zero-click IHC tools, and enhanced lab integration capabilities for increased efficiency.

HNL Lab Medicine Partners with Ibex to Bring AI Prostate Cancer Diagnostics to Its Labs

Mar 19, 2026 | Digital Pathology, Prostate

The Pennsylvania-based laboratory will integrate Ibex’s AI solution for prostate biopsies and TURP specimens into its existing digital pathology infrastructure.

Blood Test May Help Guide Breast Cancer Treatment Decisions in Women 70 and Older

Mar 19, 2026 | Breast, Cancer, Molecular Diagnostics

Researchers found that circulating tumor DNA testing could identify which older patients with estrogen receptor–positive breast cancer are less likely to respond to hormone therapy alone.

Precipio and Memorial Sloan-Kettering Publish Study on BCR::ABL1 Assay for Leukemia Monitoring

Mar 13, 2026 | Leukemia

The Bloodhound BCR::ABL1 assay simultaneously detects and quantifies all four clinically important isoforms in a single run, offering new capabilities for chronic myeloid leukemia management.

Walgreens Partners to Expand Colorectal Cancer Screening Access

Mar 13, 2026 | Colorectal

The initiative gives eligible pharmacy customers a streamlined pathway to request the Cologuard stool DNA test, with no prep or special diet required.

Hepion Pharmaceuticals Licenses ctRNA Biomarker Assay for Liver Cancer Detection

Mar 13, 2026 | Cancer

Hepion Pharmaceuticals has licensed a circulating tumor RNA assay from Cirna Diagnostics for early detection of hepatocellular carcinoma in high-risk patients, expanding its liquid biopsy portfolio for liver cancer.

Protein Biomarker Tests May Detect Cancer Earlier Than DNA-Based Methods

Mar 12, 2026 | Cancer

20/20 BioLabs argues a tiered screening approach—starting with protein-based tests before moving to circulating tumor DNA testing or imaging—could improve early-stage detection and lower costs.

Study Finds Multi-Omic Breast Cancer Test Predicts Radiation Therapy Benefit

Mar 12, 2026 | Breast

Data show the test can predict both locoregional recurrence risk and radiation therapy benefit in early-stage invasive breast cancer.

Guardant’s Shield CRC Blood Test Now Orderable Through Quest Diagnostics Network

Mar 11, 2026 | Colorectal

Physicians can now order the Shield blood test through Quest’s network of nearly 650,000 clinician and hospital accounts, patient service centers, and in-office phlebotomists.

Study Shows Dual Epigenetic Markers Improve Early Colorectal Cancer Detection

Mar 9, 2026 | Colorectal

A study reports that dual epigenetic markers in cell-free DNA achieved 95% diagnostic accuracy for stage I colorectal cancer, outperforming conventional liquid biopsy methods.

FDA Grants Breakthrough Status to Breath Test for Postoperative Pneumonia Risk

Feb 27, 2026 | Cancer, Cardiovascular, Diagnostic Technologies, Mass Spectrometry

The FDA has granted Breakthrough Device Designation to Breath Diagnostics Inc.’s OneBreath, a breath-based test that assesses postoperative pneumonia risk in cardiac surgery patients using a single preoperative sample.

Fecal DNA Methylation Test Shows Promise for Colorectal Cancer Screening

Feb 27, 2026 | Colorectal

A multicenter study reports that combining fecal SDC2 methylation testing with the APCS scoring system improves advanced adenoma detection and specificity in colorectal cancer screening.

Blood Test Could Enable Earlier Detection of Gallbladder Cancer

Feb 27, 2026 | Cancer

Researchers have identified blood-based metabolic signatures that may enable earlier, noninvasive detection of gallbladder cancer, according to findings in the Journal of Proteome Research.